Adjuvant surgery after carboplatin and VP16 in resectable small cell lung cancer

Journal of Thoracic Oncology

Volumn 2, Issue 2, 2007, Pages 131-134

  Veronesi, Giulia ^a   Scanagatta, Paolo ^a   Leo, Francesco ^a   De Pas, Tommaso ^a   Pelosi, Giuseppe ^a   Catalano, Gianpiero ^a   Gandini, Sara ^a   De Braud, Filippo ^a   Spaggiari, Lorenzo ^a,b  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Chemotherapy; Induction treatment; Small cell lung cancer; Surgery

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; IFOSFAMIDE; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LOBECTOMY; LOG RANK TEST; LUNG RESECTION; LUNG SMALL CELL CANCER; LYMPH NODE DISSECTION; MALE; MORBIDITY; MORTALITY; MULTIPLE CYCLE TREATMENT; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENCE RISK; SURGEON; THORACOTOMY; TREATMENT RESPONSE; LUNG TUMOR; MIDDLE AGED; POSITRON EMISSION TOMOGRAPHY; PROSPECTIVE STUDY; SMALL CELL CARCINOMA; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, SMALL CELL; CISPLATIN; ETOPOSIDE; FEMALE; HUMANS; IFOSFAMIDE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PNEUMONECTOMY; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 34247106264     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1016/S1556-0864(15)30040-X     Document Type: Article

References (19)

1. Fox W, Scadding JG. Medical Research Council comparative trial of surgery and radiotherapy for primary treatment of small-celled or oat-celled carcinoma of bronchus. Ten-year follow-up. Lancet 1973;14:63-65.
2. Osterlind K, Hansen M, Hansen HH, et al. Treatment policy of surgery in small cell carcinoma of the lung: retrospective analysis of a series of 874 consecutive patients. Thorax 1985;40:272-277.
3. Lad T, Piantadosi S, Thomas P, et al. A prospective randomized trial to determine the benefit of surgical resection of residual disease following response of SCLC to combination chemotherapy. Chest 1994;106:320S-323S.
4. Shields TW, Higgins GA Jr, Matthews MJ, et al. Surgical resection in the management of small cell carcinoma of the lung. J Thorac Cardiovasc Surg 1982;84:481-488.
5. Shepherd FA, Ginsberg RJ, Patterson GA, et al. A prospective study of adjuvant surgical resection after chemotherapy for limited SCLC. A University of Toronto Lung Oncology Group study. Thorac Cardiovasc Surg 1989;97:177-186.
6. Prager RL, Foster JM, Hainsworth JD, et al. The feasibility of adjuvant surgery in limited-stage small cell carcinoma: a prospective evaluation. Ann Thorac Surg 1984;38:622-626.
7. Lucchi M, Mussi A, Chella A, et al. Surgery in the management of SCLC. Eur J Cardiothorac Surg 1997;12:689-693.
8. Fujimori K, Yokoyama A, Kurita Y, et al. A pilot phase 2 study of surgical treatment after induction chemotherapy for resectable stage I to IIIA SCLC. Chest 1997;111:1089-1093.
9. Brock MV, Hooker CM, Syphard JE, et al. Surgical resection of limited disease SCLC in the new era of platinum chemotherapy: its time has come. J Thorac Cardiovasc Surg 2005;129:64-72.
10. Rami-Porta R, Wittekind C, Goldstraw P International Association for the Study of Lung Cancer (IASLC) Staging Committee. Complete resection in lung cancer surgery: proposed definition. Lung Cancer 2005;49:25-33.
11. Calvert AH, Newell DR, Gumbrell LA, et al. Carboplatin dosage: prospect of evaluation of a simple formula based on renal function. J Clin Oncol 1989;7:1748-1756.
12. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. JNCI 2002;92:205-216.
13. Meyer JA. Indications for surgical treatment in small cell carcinoma of the lung. Surg Clin North Am 1987;67:1103-1105.
14. Nakamura H, Kato Y, Kato H. Outcome of surgery for small cell lung cancer - response to induction chemotherapy predicts survival. Thorac Cardiovasc Surg 2004;52:206-210.
15. Glisson B, Scott C, Komaki R, et al. Cisplatin, ifosfamide, oral etoposide, and concurrent accelerated hyperfractionated thoracic radiation for patients with limited small-cell lung carcinoma: results of radiation therapy oncology group trial 93-12. J Clin Oncol 2000;18:2990-2995.
16. Rea F, Callegaro D, Favaretto A, et al. Long term results of surgery and chemotherapy in SCLC. Eur J Cardiothorac Surg 1998;14:398-402.
17. Hügli A, Moro D, Mermillod B, et al. Phase II trial of up-front accelerated thoracic radiotherapy combined with chemotherapy and optional up-front prophylactic cranial irradiation in limited small-cell lung cancer. J Clin Oncol 2000;18:1662-1667.
18. Eberhardt W, Stamatis G, Stuschke M, et al. Prognostically orientated multimodality treatment including surgery for selected patients of small-cell lung cancer patients stages IB to IIIB: long-term results of a phase II trial. Br J Cancer 1999;81:1206-1212.
19. Bradley JD, Dehdashti F, Mintun MA, et al. Positron emission tomography in limited-stage small-cell lung cancer: a prospective study. J Clin Oncol 2004;15:3248-3254.